Eli Lilly's Zepbound Gets a Significant Price Drop: What It Means for Patients and the Market
The Ongoing Fight for Affordable Healthcare in America
A Federal Challenge to California Healthcare: Kevin Kiley's Bid to Rein in Costs
Navigating the Future of Healthcare: The GOP's Approach to Obamacare Subsidies
The Looming Healthcare Question: Trump's Stance on Obamacare Tax Credits
Governor Healey's Healthcare Hot Potato: 'Talk to Trump' on Skyrocketing Costs
The Looming Health Insurance Cliff: Will Congress Extend Obamacare Subsidies?
America's Healthcare Divide: A Looming Battle Over Obamacare Subsidies
The Healthcare Tightrope: Will Subsidies Vanish, Leaving Millions Stranded?
A Doctor's Urgent Plea: Making Healthcare a Right, Not a Luxury, in India
Reimagining American Healthcare: JD Vance Highlights Trump Administration's Drive to Fix a "Screwed Up" System
The Scales of Justice: Lahore High Court Reaffirms PHC's Grip on Healthcare Costs
A Financial Cliff Edge: Oklahoma's Healthcare Subsidy Crisis Looms
The Enduring Quandary of Healthcare Costs: Are Subsidies a Symptom or the Solution?
The Empty Chair and California's Health Future: A Gubernatorial Crossroads
The Bitter Pill: How Deregulation Left Pakistan's Sick in a Squeeze
The Unsettling Countdown: How a Fading Federal Lifeline Could Strain Utah's Wallets and Health
Beyond the Red and Blue: Florida's Cancer Crisis and the Crushing Burden of Care
The Looming Healthcare Cliff: When Affordability Vanishes for Millions
The Quiet Revolution: How Federal Officials Are Fighting for Cheaper Biotech Drugs
The Rx Revolution: How Startups Are Rewriting the Rules of Drug Affordability
Trump Unveils Bold Strategy to Drastically Cut IVF Costs for American Families
The Looming Healthcare Cliff: Democrats Push for Permanent ACA Subsidies to Avert Crisis
A Looming Crisis: How a Government Shutdown Threatens Vital Healthcare Subsidies for 60,000 New Hampshire Families
The Enduring Saga of Drug Prices: Trump's Lingering Shadow on Healthcare Affordability
Democrats Stand Firm: The Battle to Secure Affordable Healthcare Subsidies
The GLP-1 Drug Dilemma: Insurers Battle Costs While Patients Face Uncertain Future
A Health Insurance Time Bomb: Millions Stare Down Skyrocketing Premiums
Decoding India's Healthcare Horizon: The GST Reform Ripple Effect on Medicines, Diagnostics, and Insurance
A Landmark Decision: Zero GST on Life-Saving Medicines and Rare Disease Drugs
The Looming Crisis: Ensuring Dignified Healthcare for India's Ageing Population
The Unsung Heroes: How Indian Pharma Dodged Trump's Tariff Storm
A New Dawn for Senior Healthcare: Unpacking the GST Relief
A Breakthrough in Affordability: Ozempic Now Half Price for Cash Customers Through GoodRx Partnership